Nanoparticles can directly tackle cancer cells
Health Europa - 13-Aug-2018Nanoparticles reduce drug toxicity and promote cancer cell targeting
Join the club for FREE to access the whole archive and other member benefits.
Professorial Research Fellow at University of East Anglia.
Prof Pshezhetskiy has received an MSc (summa cum laude) from Lomonosov Moscow State University in 2000. He has completed his PhD in Moscow State/Montreal Universities in 2003 and has carried out post-doctoral research in Paul Sabatier University, Toulouse (2003-2005) and CNRS Institute of Structural Biology and Pharmacology, Toulouse (2005-2006). During this period, he also worked as a visiting scientist at McGill University, Canada. In 2006 Prof Pshezhetskiy joined Imperial College London as a Research Fellow/Head of the Tumour Microenvironment and Chemotherapy group. Since April 2012 he has held an Honorary Senior Lectureship at the Norwich Medical School, UEA. His current research interests include the molecular mechanisms of cancer pathogenesis, inflammatory response, cancer biomarkers and novel targeted therapies.
Visit website: https://people.uea.ac.uk/d_pshezhetskiy
See also: Norwich Medical School, UEA - Medical school on University of East Anglia (UEA).
Details last updated 17-Jan-2020
Nanoparticles reduce drug toxicity and promote cancer cell targeting